Search

Your search keyword '"Halaby, Rim"' showing total 50 results

Search Constraints

Start Over You searched for: Author "Halaby, Rim" Remove constraint Author: "Halaby, Rim"
50 results on '"Halaby, Rim"'

Search Results

11. Enrollment of Older Patients, Women, and Racial and Ethnic Minority Individuals in Valvular Heart Disease Clinical Trials

13. Patient and Staff Perceptions of Universal Severe Acute Respiratory Syndrome Coronavirus 2 Screening Prior to Cardiac Catheterization and Electrophysiology Laboratory Procedures

15. Racial, Ethnic, and Socioeconomic Inequities in Access to Left Atrial Appendage Occlusion

18. Triple Antiplatelet Therapy and Combinations with Oral Anticoagulants After Stent Implantation

20. Extended-Duration Betrixaban Reduces the Risk of Stroke Versus Standard-Dose Enoxaparin Among Hospitalized Medically Ill Patients: An APEX Trial Substudy (Acute Medically Ill Venous Thromboembolism Prevention With Extended Duration Betrixaban)

24. d-Dimer elevation and adverse outcomes

25. EMBRACE STEMI study: a Phase 2a trial to evaluate the safety, tolerability, and efficacy of intravenous MTP-131 on reperfusion injury in patients undergoing primary percutaneous coronary intervention

33. Contributors

34. Extended-Duration Betrixaban Reduces the Risk of Stroke Versus Standard-Dose Enoxaparin Among Hospitalized Medically Ill Patients

38. The safety and efficacy of full- versus reduced-dose betrixaban in the Acute Medically Ill VTE (Venous Thromboembolism) Prevention With Extended-Duration Betrixaban (APEX) trial

39. Association of D-dimer Levels with Clinical Event Rates and the Efficacy of Betrixaban versus Enoxaparin in the APEX Trial

40. Extended Thromboprophylaxis with Betrixaban in Acutely Ill Medical Patients

41. The Safety and Efficacy of Full Versus Reduced Dose Betrixaban in the Acute Medically Ill VTE (Venous Thromboembolism) Prevention with Extended Duration Betrixaban (APEX) Trial

42. EMBRACE STEMI study: a Phase 2a trial to evaluate the safety, tolerability, and efficacy of intravenous MTP-131 on reperfusion injury in patients undergoing primary percutaneous coronary intervention

43. Extended-Duration Thromboprophylaxis Among Acute Medically Ill Patients

45. INTRACORONARY BIVALIRUDIN ADMINISTRATION IN STEMI IMPROVES CORONARY FLOW

48. d-Dimer elevation and adverse outcomes

49. Extended-Duration Thromboprophylaxis Among Acute Medically Ill Patients: An Unmet Need.

50. Transcatheter Myotomy to Reduce Left Ventricular Outflow Obstruction.

Catalog

Books, media, physical & digital resources